|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.3%
19.24
3,848
USD
|
200
-1.3%
|
19.24
|
3,848
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.6%
19.08
1,908
USD
|
100
-0.6%
|
19.08
|
1,908
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
95
-0.6%
19.14
1,818
USD
|
95
-0.6%
|
19.14
|
1,818
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
5
-0.0%
19.17
96
USD
|
5
-0.0%
|
19.17
|
96
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.6%
18.84
1,884
USD
|
100
-0.6%
|
18.84
|
1,884
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.6%
18.78
1,878
USD
|
100
-0.6%
|
18.78
|
1,878
USD
|
|
|
2010-01-06 |
2010-01-04 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.6%
18.75
1,875
USD
|
100
-0.6%
|
18.75
|
1,875
USD
|
|
|
2009-10-07 |
2009-10-06 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
22.00
2,200
USD
|
100
-0.7%
|
22.00
|
2,200
USD
|
|
|
2009-10-07 |
2009-10-06 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
900
-6.1%
22.00
19,800
USD
|
900
-6.1%
|
22.00
|
19,800
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.78
2,478
USD
|
100
-0.7%
|
24.78
|
2,478
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.95
2,495
USD
|
100
-0.7%
|
24.95
|
2,495
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.15
2,415
USD
|
100
-0.7%
|
24.15
|
2,415
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.29
2,429
USD
|
100
-0.7%
|
24.29
|
2,429
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.58
2,458
USD
|
100
-0.7%
|
24.58
|
2,458
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.77
2,477
USD
|
100
-0.7%
|
24.77
|
2,477
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
24.85
2,485
USD
|
100
-0.7%
|
24.85
|
2,485
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
25.00
2,500
USD
|
100
-0.7%
|
25.00
|
2,500
USD
|
|
|
2009-09-22 |
2009-09-17 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.4%
24.47
4,894
USD
|
200
-1.4%
|
24.47
|
4,894
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
400
+6.9%
18.95
7,580
USD
|
400
+6.9%
|
18.95
|
7,580
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
300
+5.5%
18.96
5,688
USD
|
300
+5.5%
|
18.96
|
5,688
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
1,600
+41.0%
19.00
30,400
USD
|
1,600
+41.0%
|
19.00
|
30,400
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
1,000
+34.5%
19.02
19,020
USD
|
1,000
+34.5%
|
19.02
|
19,020
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
200
+7.4%
19.03
3,806
USD
|
200
+7.4%
|
19.03
|
3,806
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
300
+12.5%
19.04
5,712
USD
|
300
+12.5%
|
19.04
|
5,712
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
700
+41.2%
19.05
13,335
USD
|
700
+41.2%
|
19.05
|
13,335
USD
|
|
|
2009-07-10 |
2009-07-10 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
500
+41.7%
19.08
9,540
USD
|
500
+41.7%
|
19.08
|
9,540
USD
|
|
|
2009-07-10 |
2009-07-08 |
B
Purchase
|
Freund John Gordon
Non-Executive Director
|
130,000
+12.3%
19.00
2,470,000
USD
|
130,000
+12.3%
|
19.00
|
2,470,000
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.18
2,318
USD
|
100
-0.7%
|
23.18
|
2,318
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.44
2,344
USD
|
100
-0.7%
|
23.44
|
2,344
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.37
2,337
USD
|
100
-0.7%
|
23.37
|
2,337
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.4%
23.28
4,656
USD
|
200
-1.4%
|
23.28
|
4,656
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.4%
23.21
4,642
USD
|
200
-1.4%
|
23.21
|
4,642
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.23
2,323
USD
|
100
-0.7%
|
23.23
|
2,323
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.05
2,305
USD
|
100
-0.7%
|
23.05
|
2,305
USD
|
|
|
2009-07-02 |
2009-07-01 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
23.57
2,357
USD
|
100
-0.7%
|
23.57
|
2,357
USD
|
|
|
2009-06-15 |
2009-06-11 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
1,000
-6.8%
22.00
22,000
USD
|
1,000
-6.8%
|
22.00
|
22,000
USD
|
|
|
2009-03-26 |
2009-03-25 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
544
-4.0%
22.00
11,968
USD
|
544
-4.0%
|
22.00
|
11,968
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.80
2,680
USD
|
100
-0.8%
|
26.80
|
2,680
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.93
2,693
USD
|
100
-0.8%
|
26.93
|
2,693
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.96
2,696
USD
|
100
-0.8%
|
26.96
|
2,696
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.87
2,687
USD
|
100
-0.8%
|
26.87
|
2,687
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.85
2,685
USD
|
100
-0.8%
|
26.85
|
2,685
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.5%
26.94
5,388
USD
|
200
-1.5%
|
26.94
|
5,388
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
27.12
2,712
USD
|
100
-0.7%
|
27.12
|
2,712
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.95
2,695
USD
|
100
-0.7%
|
26.95
|
2,695
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.92
2,692
USD
|
100
-0.7%
|
26.92
|
2,692
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.83
2,683
USD
|
100
-0.7%
|
26.83
|
2,683
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
200
-1.4%
26.79
5,358
USD
|
200
-1.4%
|
26.79
|
5,358
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
99
-0.7%
26.89
2,662
USD
|
99
-0.7%
|
26.89
|
2,662
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
1
-0.0%
26.91
27
USD
|
1
-0.0%
|
26.91
|
27
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.81
2,681
USD
|
100
-0.7%
|
26.81
|
2,681
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.75
2,675
USD
|
100
-0.7%
|
26.75
|
2,675
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.62
2,662
USD
|
100
-0.7%
|
26.62
|
2,662
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.49
2,649
USD
|
100
-0.7%
|
26.49
|
2,649
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.72
2,672
USD
|
100
-0.7%
|
26.72
|
2,672
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.64
2,664
USD
|
100
-0.7%
|
26.64
|
2,664
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.26
2,626
USD
|
100
-0.7%
|
26.26
|
2,626
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
27.10
2,710
USD
|
100
-0.7%
|
27.10
|
2,710
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.97
2,697
USD
|
100
-0.7%
|
26.97
|
2,697
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.87
2,687
USD
|
100
-0.7%
|
26.87
|
2,687
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.56
2,656
USD
|
100
-0.7%
|
26.56
|
2,656
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.7%
26.28
2,628
USD
|
100
-0.7%
|
26.28
|
2,628
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
29
-0.2%
26.67
773
USD
|
29
-0.2%
|
26.67
|
773
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
71
-0.5%
26.63
1,891
USD
|
71
-0.5%
|
26.63
|
1,891
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
26.94
2,694
USD
|
100
-0.8%
|
26.94
|
2,694
USD
|
|
|
2009-02-03 |
2009-02-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.8%
27.01
2,701
USD
|
100
-0.8%
|
27.01
|
2,701
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-1.0%
27.22
2,722
USD
|
100
-1.0%
|
27.22
|
2,722
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-1.0%
27.00
2,700
USD
|
100
-1.0%
|
27.00
|
2,700
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
8
-0.1%
26.53
212
USD
|
8
-0.1%
|
26.53
|
212
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
27.35
2,735
USD
|
100
-0.9%
|
27.35
|
2,735
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
26.97
2,697
USD
|
100
-0.9%
|
26.97
|
2,697
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
26.94
2,694
USD
|
100
-0.9%
|
26.94
|
2,694
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
26.10
2,610
USD
|
100
-0.9%
|
26.10
|
2,610
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
26.09
2,609
USD
|
100
-0.9%
|
26.09
|
2,609
USD
|
|
|
2009-01-06 |
2009-01-02 |
PS
Planned sale
|
Cundy Kenneth C
SVP, Preclinical Development
Officer
|
100
-0.9%
26.18
2,618
USD
|
100
-0.9%
|
26.18
|
2,618
USD
|
|
